FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1196.96

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1196.96
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.96/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96
Version20190511
Statusactive
Date2019-05-11T01:00:10-04:00
NameCPICRxNORMAtazanavirSCDG
TitleCPIC RxNORM atazanavir SCDG
Realmus
Authorityhl7
DescriptionWe have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are seen with systemically administered medications. Elimu OID: 2019.05.14.10.51
Purpose(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Exclusion Criteria: None)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1196.96",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Elimu Informatics Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2019-05-11"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1196.96"
    }
  ],
  "version": "20190511",
  "name": "CPICRxNORMAtazanavirSCDG",
  "title": "CPIC RxNORM atazanavir SCDG",
  "status": "active",
  "experimental": false,
  "date": "2019-05-11T01:00:10-04:00",
  "publisher": "Elimu Informatics Steward",
  "description": "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are seen with systemically administered medications.\nElimu OID: 2019.05.14.10.51",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Exclusion Criteria: None)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1154364",
            "display": "Atazanavir Oral Product"
          },
          {
            "code": "1154365",
            "display": "Atazanavir Pill"
          },
          {
            "code": "1598983",
            "display": "Atazanavir Oral Powder Product"
          },
          {
            "code": "1601650",
            "display": "Atazanavir / cobicistat Oral Product"
          },
          {
            "code": "1601651",
            "display": "Atazanavir / cobicistat Pill"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:72f0ba7b-0cad-4bf2-8b91-bec37aed7c06",
    "timestamp": "2025-05-23T19:14:09-04:00",
    "total": 5,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1154364",
        "display": "atazanavir Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1154365",
        "display": "atazanavir Pill"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1598983",
        "display": "atazanavir Oral Powder Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1601650",
        "display": "atazanavir / cobicistat Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1601651",
        "display": "atazanavir / cobicistat Pill"
      }
    ]
  }
}